Consumers who bought a popular cough syrup could be eligible for money ... million to resolve claims it advertised the product as “non-drowsy” despite containing an ingredient that could ...

Robitussin was at the center of a class-action complaint over its “non-drowsy” cough and cold medicines. Screengrab from Calchi, et al. v. GlaxoSmithKline Consumer Healthcare Holdings (US ...

It also agreed not to describe the products as “non-drowsy” in future advertisements, the website said. Consumers who bought the included Robitussin products between Feb. 16, 2016 and Jan. 21 ...